← Leaderboards
Arif Hussain
Baltimore Va Medical Center
$0
Attributed
$0
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2009–21$1$1$1$0$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
VA$0 · 1
By mechanism
I01$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Signal Pathway”
- David Heimbrook · Leidos Biomedical Research, Inc.$191,912,844
- Asrar B. Malik · University Of Illinois At Chicago$75,811,832
- Robert H Tukey · University Of California San Diego$50,504,865
- Meenhard Herlyn · University Of Pennsylvania$50,308,097
- Ian A Wilson · Scripps Research Institute, The$50,300,809
- Richard D Smith · Battelle Pacific Northwest Laboratories$46,192,560
Research focus
Signal PathwayResistancePathway InteractionsRecurrenceMetastatic Prostate CancerMalignant NeoplasmsEffective TherapyIn VitroPreclinical StudyRadiationClinically RelevantIn VivoAndrogensMalignant Neoplasm Of ProstateDisorder ControlCancer PatientDocetaxelApoptosisCellsInhibitor/AntagonistBaseChemotherapyAndrogen Independent Prostate CancerSignal Transduction
Grant awards (9)
Multi-Faceted Targeting of Treatment-Sensitive and Treatment-Resistant Prostate Cancer$0
I01 · FY2021 · VA · contact PI
Multi-Faceted Targeting of Treatment-Sensitive and Treatment-Resistant Prostate Cancer$0
I01 · FY2020 · VA · contact PI
Multi-Faceted Targeting of Treatment-Sensitive and Treatment-Resistant Prostate Cancer$0
I01 · FY2019 · VA · contact PI
Multi-Faceted Targeting of Treatment-Sensitive and Treatment-Resistant Prostate Cancer$0
I01 · FY2018 · VA · contact PI
Multi-Faceted Targeting of Treatment-Sensitive and Treatment-Resistant Prostate Cancer$0
I01 · FY2017 · VA · contact PI
Optimization of Multi-Modal Therapies in Pre-clinical models of Prostate Cancer$0
I01 · FY2014 · VA · contact PI
Optimization of Multi-Modal Therapies in Pre-clinical models of Prostate Cancer$0
I01 · FY2013 · VA · contact PI
Optimization of Multi-Modal Therapies in Pre-clinical models of Prostate Cancer$0
I01 · FY2012 · VA · contact PI
Optimization of Multi-Modal Therapies in Pre-clinical models of Prostate Cancer$0
I01 · FY2009 · VA · contact PI